Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery

Clinical trial NCT04521140 · COMPLETED

Trial details

NCT number: NCT04521140
Sponsor: Nicole Fram M.D.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Corneal Edema Corneal Defect Corneal Transplant Penetrating KeratoPlasty Anterior Chamber Inflammation Ocular Pain Intraocular Pressure

Start date: 2020-10-16
Primary completion: 2023-01-04
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.